CAT and glioblastoma: Nanjaiah et al. also reported that activation of N-methyl-D-aspartate receptor (NMDAR) attenuated the intracellular ROS production and significantly enhanced the cell viability in LN18 and U251MG glioblastoma cells by increasing CAT activity.